INSIGHTS ON DRUG DEVELOPMENT

  • Cost And Scalability Key Drivers Of Expanded Gene Therapy Access
    5/16/2025

    Gene therapies are expanding beyond rare diseases, but high costs hinder access. Discover how innovations in viral vector manufacturing could make these breakthroughs more affordable.

  • Simplify Your Cell Culture Processes
    11/13/2025

    Discover bioreactors that combine fast setup, robust design, and scalable performance to streamline cell culture workflows, which help you move from uncertainty to control, no matter your molecule.

  • Eliminate Risk From Your Viral Vector Tech Transfers
    12/5/2025

    Explore strategies to simplify viral vector tech transfers, reduce risk, and maintain quality under tight timelines, as well as a case study that demonstrates how to streamline this critical process.

  • Facts About AAV Producer Cell Lines
    8/8/2025

    Gene therapies are revolutionizing medicine, with AAV vectors leading the way. As production evolves, stable cell lines may replace transient transfection and unlock scalable solutions.

  • Analyzing Biological Drug Effects In 3D
    10/24/2025

    Explore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.

DRUG DEVELOPMENT SOLUTIONS

  • Discover the benefits of partnering with a CDMO that offers expanding capacity and capabilities and a far-reaching operational footprint to support your project.

  • Malvern 2000 Laser Diffraction Particle Size Analyzer with (1) Malvern Model Scirocco 2000, Dry Power Tray Sampler, and (1) Malvern Model Hydro 2000S, Liquid Test Module.

  • Explore how modern CMC approaches integrate advanced chemistry, scalable manufacturing, and strong analytics to streamline development, boost reliability, and sustain momentum to commercial supply.

  • Designed for today’s assays and tomorrow’s breakthroughs—flexible detection that evolves with your science.

    The SpectraMax® iD3s and iD5e Multi-Mode Microplate Readers deliver flexible, scalable solutions for absorbance, fluorescence, and luminescence assays—with advanced capabilities for evolving research needs. The iD3s reader offers a streamlined, affordable platform with a tunable monochromator and temperature control, while the iD5e reader adds enhanced detection modes including time-resolved fluorescence (TRF) and tunable fluorescence polarization (FP) and can be expanded to include TR-FRET, HTRF, BRET and western blot. Both readers support on board fluidics with optional dual injectors.

  • These patented synthesis columns offer oligonucleotide manufacturers a system designed for efficiency and safety.